Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
常规交易时段
US$64.00
−US$0.11 · -0.17%
盘中时间采用ET。市场数据可能有所延迟。
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
日内区间
当前US$64.00
52周区间
当前US$64.00
盘中时间采用ET。市场数据可能有所延迟。
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
日内区间
当前US$64.00
52周区间
当前US$64.00
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(USD) | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 104.01亿 USD | 99.11亿 USD | 94.55亿 USD | 87.17亿 USD | 82.91亿 USD |
| 销货成本 | 46.56亿 USD | 43.99亿 USD | 42.08亿 USD | 39.69亿 USD | 36.39亿 USD |
| 毛利 | 57.45亿 USD | 55.12亿 USD | 52.47亿 USD | 47.48亿 USD | 46.52亿 USD |
| 研究与开发 | 9.9亿 USD | 8.76亿 USD | 8.59亿 USD | 7.02亿 USD | 8.42亿 USD |
| 销售、一般及管理费用 | 34.49亿 USD | 32.5亿 USD | 32.09亿 USD | 30.68亿 USD | 30.76亿 USD |
| 营业费用 | 43.85亿 USD | 40.99亿 USD | 42.08亿 USD | 40.76亿 USD | 40.72亿 USD |
| 利息收入 | 7400万 USD | 8145.4万 USD | 3400万 USD | 1652.49万 USD | 300.64万 USD |
| 利息支出 | 2.04亿 USD | 1.86亿 USD | 1.89亿 USD | 1.38亿 USD | 1.2亿 USD |
| 折旧和摊销 | 13.35亿 USD | 12.28亿 USD | 12.21亿 USD | 11.23亿 USD | 12.19亿 USD |
| 营业利润 | 13.6亿 USD | 14.13亿 USD | 10.39亿 USD | 6.72亿 USD | 5.8亿 USD |
| 净利润 | 9.8亿 USD | 10.18亿 USD | 9.74亿 USD | 3.35亿 USD | 3.76亿 USD |
公司数据更新于 2026年10月12日。
近期已公布业绩
近期已公布业绩
报告持有此股票敞口的交易所交易基金。
Kovitz Core Equity ETFEQTY3944.72万3.06%14.27亿 USD0.99%US$29.50+0.20%
Dimensional - International Value ETFDFIV3099.27万0.15%213.87亿 USD0.27%US$55.567+0.27%
Dimensional - International Core Equity Market ETFDFAI1707.9万0.10%177.82亿 USD0.18%US$41.335-0.01%
Dimensional - International Core Equity 2 ETFDFIC1414.55万0.10%150.17亿 USD0.22%US$37.515-0.04%
Dimensional World ex U.S. Core Equity 2 ETFDFAX737.78万0.06%123.36亿 USD0.28%US$37.04-0.11%
Running Oak Efficient Growth ETFRUNN674.68万1.73%3.89亿 USD0.58%US$33.42+0.36%
John Hancock Investments - Multifactor Developed International ETFJHMD299.09万0.31%9.65亿 USD0.39%US$44.08-0.02%
Invesco RAFI Developed Markets ex-U.S. ETFPXF288.56万0.10%29.06亿 USD0.43%US$75.76-0.17%
Kovitz Core Equity ETFEQTY
Dimensional - International Value ETFDFIV
Dimensional - International Core Equity Market ETFDFAI
Dimensional - International Core Equity 2 ETFDFIC
Dimensional World ex U.S. Core Equity 2 ETFDFAX
Running Oak Efficient Growth ETFRUNN
John Hancock Investments - Multifactor Developed International ETFJHMD
Invesco RAFI Developed Markets ex-U.S. ETFPXFAI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。